UCB S.A. | Key People and Executives
Evelyn du Monceau
Chairman
Jean-Christophe Tellier
Chief Executive Officer & Executive Director
Roch F. Doliveux
Director
Jonkheer Cédric van Rijckevorsel
Director
Charles-Antoine Janssen
Director
Norman J. Ornstein
Independent Director
Viviane Monges
Independent Director
Pierre Gurdjian
Vice Chairman
Kay Dame Davies
Independent Director
Ulf Arne Wiinberg
Independent Director
Alice Dautry
Independent Director
Albrecht de Graeve
Independent Director
Evelyn du Monceau
Chairman
Jean-Christophe Tellier
Chief Executive Officer & Executive Director
Charl van Zyl
Chief Operating Officer
Detlef Thielgen
Chief Financial Officer & Executive Vice President
Dhavalkumar Patel
Chief Scientific Officer & EVP
Herman de Prins
Chief Information Officer
Iris Löw-Friedrich
Chief Medical Officer & Executive Vice President
Dominique Baeten
Head-New Patient Value Mission
Jean Luc Fleurial
Chief Talent Officer
Alexander Moscho
Chief Strategy Officer & Executive Vice President
Pascale Richetta
Executive Vice President
Neil Weir
Senior Vice President-Discovery
Emmanuel Caeymaex
Executive VP & Unit Head-Immunology Patient Value
Roch F. Doliveux
Director
Jonkheer Cédric van Rijckevorsel
Director
Charles-Antoine Janssen
Director
Raf Remijsen
Head-Treasury & Risk Management
Bharat Tewarie
Chief Marketing Officer & Executive VP
Cristina C. Bautista
Senior Director-Global Internal Audit
Caroline Vancoillie
Chief Accountant Officer
Nathalie Deldime
Manager-Investor Relations
Isabelle Ghellynck
Associate Director-Investor Relations
Antje Witte
Vice President-Investor Relations
Laurent Schots
Head-Corporate Communications & Media Relations
Xavier Michel
Secretary & Vice President
Anna S. Richo
Executive Vice President & General Counsel
Norman J. Ornstein
Independent Director
Viviane Monges
Independent Director
Pierre Gurdjian
Vice Chairman
Kay Dame Davies
Independent Director
Ulf Arne Wiinberg
Independent Director
Alice Dautry-Varsat
Independent Director
Albrecht de Graeve
Independent Director
| Address |
Allée de la Recherche, 60
Brussels BU 1070
Belgium
|
|
Employees
|
- |
| Website |
http://www.ucb.com |
| Updated |
07/08/2019 |
| UCB SA engages in the research, development, and commercialization of pharmaceutical and biotechnology products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium. |
